161 related articles for article (PubMed ID: 35006452)
1. miR-221/222 sponge abrogates tamoxifen resistance in ER-positive breast cancer cells through restoring the expression of ERα.
Ouyang YX; Feng J; Wang Z; Zhang GJ; Chen M
Mol Biomed; 2021 Jun; 2(1):20. PubMed ID: 35006452
[TBL] [Abstract][Full Text] [Related]
2. Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells.
Phuong NT; Kim SK; Im JH; Yang JW; Choi MC; Lim SC; Lee KY; Kim YM; Yoon JH; Kang KW
Oncotarget; 2016 Mar; 7(12):13902-16. PubMed ID: 26418898
[TBL] [Abstract][Full Text] [Related]
3. Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells.
Wei Y; Lai X; Yu S; Chen S; Ma Y; Zhang Y; Li H; Zhu X; Yao L; Zhang J
Breast Cancer Res Treat; 2014 Sep; 147(2):423-31. PubMed ID: 25007959
[TBL] [Abstract][Full Text] [Related]
4. miR-125a-3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor-positive breast cancer.
Zheng L; Meng X; Li X; Zhang Y; Li C; Xiang C; Xing Y; Xia Y; Xi T
FASEB J; 2018 Feb; 32(2):588-600. PubMed ID: 28939591
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells.
Moon SY; Lee H; Kim S; Hong JH; Chun SH; Lee HY; Kang K; Kim HS; Won HS; Ko YH
BMC Cancer; 2021 Aug; 21(1):931. PubMed ID: 34407787
[TBL] [Abstract][Full Text] [Related]
6. MiR-148a and miR-152 reduce tamoxifen resistance in ER+ breast cancer via downregulating ALCAM.
Chen MJ; Cheng YM; Chen CC; Chen YC; Shen CJ
Biochem Biophys Res Commun; 2017 Feb; 483(2):840-846. PubMed ID: 28063929
[TBL] [Abstract][Full Text] [Related]
7. MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.
Cui J; Yang Y; Li H; Leng Y; Qian K; Huang Q; Zhang C; Lu Z; Chen J; Sun T; Wu R; Sun Y; Song H; Wei X; Jing P; Yang X; Zhang C
Oncogene; 2015 Jul; 34(30):3895-907. PubMed ID: 25531331
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of LINC00894-002 Contributes to Tamoxifen Resistance by Enhancing the TGF-β Signaling Pathway.
Zhang X; Wang M; Sun H; Zhu T; Wang X
Biochemistry (Mosc); 2018 May; 83(5):603-611. PubMed ID: 29738694
[TBL] [Abstract][Full Text] [Related]
9. CD36 plays a critical role in proliferation, migration and tamoxifen-inhibited growth of ER-positive breast cancer cells.
Liang Y; Han H; Liu L; Duan Y; Yang X; Ma C; Zhu Y; Han J; Li X; Chen Y
Oncogenesis; 2018 Dec; 7(12):98. PubMed ID: 30573731
[TBL] [Abstract][Full Text] [Related]
10. Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells.
Phuong NT; Kim SK; Lim SC; Kim HS; Kim TH; Lee KY; Ahn SG; Yoon JH; Kang KW
Breast Cancer Res Treat; 2011 Nov; 130(1):73-83. PubMed ID: 21170675
[TBL] [Abstract][Full Text] [Related]
11. Expression of the CD59 Glycoprotein Precursor is Upregulated in an Estrogen Receptor-alpha (ER-α)-Negative and a Tamoxifen-Resistant Breast Cancer Cell Line In Vitro.
Xiong H; Jin X; You C
Med Sci Monit; 2018 Nov; 24():7883-7890. PubMed ID: 30391994
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of TMEM47 Induces Tamoxifen Resistance in Human Breast Cancer Cells.
Men X; Su M; Ma J; Mou Y; Dai P; Chen C; Cheng XA
Technol Cancer Res Treat; 2021; 20():15330338211004916. PubMed ID: 33745390
[TBL] [Abstract][Full Text] [Related]
13. IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells.
Vaziri-Gohar A; Zheng Y; Houston KD
Mol Cancer Res; 2017 Apr; 15(4):489-497. PubMed ID: 28096479
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of estrogen receptor mRNA splice variants in the tamoxifen resistant human breast cancer cell line, MCF-7/TAMR-1 compared to the parental MCF-7 cell line.
Madsen MW; Reiter BE; Lykkesfeldt AE
Mol Cell Endocrinol; 1995 Apr; 109(2):197-207. PubMed ID: 7664983
[TBL] [Abstract][Full Text] [Related]
16. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
17. MiR-27b is epigenetically downregulated in tamoxifen resistant breast cancer cells due to promoter methylation and regulates tamoxifen sensitivity by targeting HMGB3.
Li X; Wu Y; Liu A; Tang X
Biochem Biophys Res Commun; 2016 Sep; 477(4):768-773. PubMed ID: 27363334
[TBL] [Abstract][Full Text] [Related]
18. AhR ligand aminoflavone suppresses α6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells.
Campbell PS; Mavingire N; Khan S; Rowland LK; Wooten JV; Opoku-Agyeman A; Guevara A; Soto U; Cavalli F; Loaiza-Pérez AI; Nagaraj G; Denham LJ; Adeoye O; Jenkins BD; Davis MB; Schiff R; Brantley EJ
J Cell Physiol; 2018 Jan; 234(1):108-121. PubMed ID: 30076704
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells.
Kim S; Lee J; Oh SJ; Nam SJ; Lee JE
Oncol Rep; 2015 Sep; 34(3):1613-9. PubMed ID: 26166014
[TBL] [Abstract][Full Text] [Related]
20. LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer.
Zhang H; Zhang J; Dong L; Ma R
Open Med (Wars); 2021; 16(1):68-80. PubMed ID: 33385064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]